Results 61 to 70 of about 61,338 (190)

Antidiabetic effect of Psychotria malayana Jack in induced type 1 diabetic rat

open access: yesMedisains, 2020
Background: Therapies for hyperglycemic treatment, including insulin and oral diabetes medications, have been confirmed to cause several side effects. Thus, finding new drugs with fewer side effects is of high importance.
Fairuz Fairuz   +2 more
doaj   +1 more source

Effective and Safe Glycemic Control in Patients with Diabetes Mellitus Type 2 when Using Fixed Combination of Oral Hypoglycemic Agents [PDF]

open access: yes, 2013
Diabetes mellitus (DM) type 2 is associated not only with hyperglycemia, but also with an increased atherogenic risk. Due to this glucose-lowering therapy should be not only effective, but also safe regarding the development of micro- and macrovascular ...
V.I. Pankiv
core   +1 more source

Analysis of Electrolyte Imbalance Especially Hypokalemia in Patients receiving Insulin and Oral Hypoglycemic Agents in Comparison with Patients Taking only Oral Hypoglycemic Agents in Type 2 Diabetes Mellitus Patients: A Comparative, Cross Sectional, Observational study [PDF]

open access: yes, 2020
BACKGROUND: Exogenous Insulin is the commonly prescribed drug for patients with Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hyperkalemia. Insulin acts by promoting the glucose transport into the cells through GLUT 4 transporter.
Rahul, R
core  

Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin

open access: yesClinical Medicine Insights: Case Reports, 2018
Blood glucose management in patients undergoing dialysis is clinically challenging. In this population, most conventional oral hypoglycemic agents are contraindicated, especially from the perspective of pharmacokinetics. Dipeptidyl peptidase-4 inhibitors
Takumi Minezumi   +5 more
doaj   +1 more source

Research Progress in Bioactive Compounds in Medicine Food Homologous Plants for Intervention in Diabetes [PDF]

open access: yesShipin Kexue
Diabetes mellitus (DM) is a chronic, progressive systemic disease characterized by pancreatic β-cell dysfunction and insulin resistance. The primary symptom of this disease is elevated blood glucose levels. Medicine food homologous plants (MFP) contain a
ZHOU Yixia, QIN Luqi, DIAO Rao, ZHENG Jiahuan, LIU Jiameng, FAN Bei
doaj   +1 more source

Ethnomedicinal survey of traditional antidiabetic plants in Baturraden and Sumbang

open access: yesMedisains, 2020
Background: The scientific-based jamu development program enables the development of medicinal plants in the traditional medicine system that eventual-ly can be used in the formal healthcare system.
Wahyu Utaminingrum   +2 more
doaj   +1 more source

Prescription patterns of hypoglycemic agents for elderly type 2 diabetes outpatients [PDF]

open access: yes, 2016
학위논문 (석사)-- 서울대학교 대학원 : 의학과 예방의학 전공, 2016. 2. 박병주.초 록 서론: 당뇨병은 전 세계적으로 유병률이 급증하고 있는 만성질환이다. 당뇨병환자에게 흔히 동반되는 고혈압, 이상지질혈증 역시 높은 유병률을 보이는 만성질환으로 심혈관계 질환의 위험요소 중 하나이다. 본 연구는 우리나라 외래를 방문한 65세 이상 제2형 당뇨병환자를 대상으로 그들이 사용하고 있는 혈당강하제의 처방양상 및 심혈관질환의 위험인자인 고혈압 또는
변상호
core  

Possible hypoglycemic action of SX-fraction targeting insulin signal transduction pathway [PDF]

open access: yes, 2013
Sensuke Konno, Bobby Alexander, John Zade, Muhammad ChoudhuryDepartment of Urology, New York Medical College, Valhalla, NY, USABackground: SX-fraction (SXF) is a bioactive glycoprotein with hypoglycemic activity that has been demonstrated in our pilot ...
Konno S   +3 more
core  

ALKYLGLYCIDIC ACIDS - POTENTIAL NEW HYPOGLYCEMIC AGENTS [PDF]

open access: yes, 1986
A series of alkylglycidic acid analogues and derivatives were synthesized and tested for their ability to inhibit long-chain fatty acid oxidation in vitro and to lower blood sugar in rats.
COTTRELL, SC   +5 more
core   +1 more source

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

open access: yesСахарный диабет, 2013
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic ...
Gagik Radikovich Galstyan
doaj   +1 more source

Home - About - Disclaimer - Privacy